| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| 63043_R2_RE.docx | 2021-09-13 21:46 | 88K | ||
| 63043_R2_RE_TM.docx | 2021-09-16 15:35 | 18K | ||
| 63043_R2_Table of Ma..> | 2021-09-13 21:46 | 10K | ||
| 63043fig01.jpg | 2021-09-16 17:32 | 144K | ||
| 63043fig01large.jpg | 2021-09-16 17:32 | 1.4M | ||
| 63043fig02.jpg | 2021-09-16 17:32 | 75K | ||
| 63043fig02large.jpg | 2021-09-16 17:32 | 1.6M | ||
| 63043fig03.jpg | 2021-09-16 17:32 | 110K | ||
| 63043fig03large.jpg | 2021-09-16 17:32 | 1.4M | ||
| Fig1_Scheme_FINAL.png | 2021-09-13 21:46 | 400K | ||
| Fig2_FACS_FINAL.png | 2021-09-13 21:46 | 285K | ||
| Fig3_Immune_FINAL.png | 2021-09-13 21:46 | 925K | ||
| JoVE63043.pdf | 2021-09-13 21:46 | 2.4M | ||
| JoVE63043.xml | 2021-09-13 21:46 | 11K | ||
| Rebuttal letter.docx | 2021-09-13 21:46 | 52K | ||
| Supplemental table 1..> | 2021-09-13 21:46 | 14K | ||
| Supplementary figure..> | 2021-09-13 21:46 | 12M | ||